These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18584311)

  • 1. Investigations on the humidity-induced transformations of salbutamol sulphate particles coated with L-leucine.
    Raula J; Thielmann F; Kansikas J; Hietala S; Annala M; Seppälä J; Lähde A; Kauppinen EI
    Pharm Res; 2008 Oct; 25(10):2250-61. PubMed ID: 18584311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dissolution of L-leucine-coated salbutamol sulphate aerosol particles.
    Raula J; Seppälä J; Malm J; Karppinen M; Kauppinen EI
    AAPS PharmSciTech; 2012 Jun; 13(2):707-12. PubMed ID: 22562614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel gas phase method for the combined synthesis and coating of pharmaceutical particles.
    Raula J; Lähde A; Kauppinen EI
    Pharm Res; 2008 Jan; 25(1):242-5. PubMed ID: 17952569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J; Lähde A; Kauppinen EI
    Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
    Raula J; Thielmann F; Naderi M; Lehto VP; Kauppinen EI
    Int J Pharm; 2010 Jan; 385(1-2):79-85. PubMed ID: 19879344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous synthesis and coating of salbutamol sulphate nanoparticles with L-leucine in the gas phase.
    Lähde A; Raula J; Kauppinen EI
    Int J Pharm; 2008 Jun; 358(1-2):256-62. PubMed ID: 18406087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy.
    Columbano A; Buckton G; Wikeley P
    Int J Pharm; 2002 Apr; 237(1-2):171-8. PubMed ID: 11955815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
    Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK
    Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the degree of disorder in micronized salbutamol sulfate using moisture sorption analysis.
    Gorny M; Jakobs M; Mykhaylova V; Urbanetz NA
    Drug Dev Ind Pharm; 2007 Mar; 33(3):235-43. PubMed ID: 17454056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
    Raula J; Rahikkala A; Halkola T; Pessi J; Peltonen L; Hirvonen J; Järvinen K; Laaksonen T; Kauppinen EI
    Int J Pharm; 2013 Jan; 441(1-2):248-54. PubMed ID: 23200957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into water interactions with amorphous and milled salbutamol sulphate: the development of predictive models for uptake and recrystallization.
    Grisedale LC; Belton PS; Jamieson MJ; Barker SA; Craig DQ
    Int J Pharm; 2012 Jan; 422(1-2):220-8. PubMed ID: 22100976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation.
    Chiou H; Li L; Hu T; Chan HK; Chen JF; Yun J
    Int J Pharm; 2007 Feb; 331(1):93-8. PubMed ID: 17052870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug permeation and cellular interaction of amino acid-coated drug combination powders for pulmonary delivery.
    Vartiainen V; Bimbo LM; Hirvonen J; Kauppinen EI; Raula J
    Int J Pharm; 2016 May; 504(1-2):89-97. PubMed ID: 27034001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation.
    Hu T; Chiou H; Chan HK; Chen JF; Yun J
    J Pharm Sci; 2008 Feb; 97(2):944-9. PubMed ID: 17722000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W; Ticehurst MD; Murphy J; Nokhodchi A
    J Pharm Sci; 2011 Jul; 100(7):2665-84. PubMed ID: 21268026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability.
    Ward GH; Schultz RK
    Pharm Res; 1995 May; 12(5):773-9. PubMed ID: 7479567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
    Gaisford S; Dennison M; Tawfik M; Jones MD
    Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.